Syrleno 5 mg tabletе
| Name | Syrleno 5 mg tabletе |
|---|---|
| Marketing Authorisation Number | HR-H-283434932 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 5 mg everolimusa |
| Pharmaceutical Form | Tableta |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska Synthon BV, Nijmegen, Nizozemska Alkaloid - INT d.o.o., Ljubljana - Črnuče, Slovenija |
| Marketing Authorisation Holder | Alkaloid - INT d.o.o., Šlandrova ulica 4, Ljubljana - Črnuče, Slovenija |
| Marketing Authorisation Date | 30.06.2026 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/25-02/128 |
| Registration Number | 381-12-01/286-26-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EG02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Summary of risk management plan | download |
